See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Presenter: Felix Mahfoud

October 23, 2012

Presentation TCT 2012

How to Become Trained and Start a LAA Closure Program

Presenter: Brian Whisenant

October 23, 2012

Presentation TCT 2012

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

Presenter: Eugenio Stabile

October 23, 2012

Presentation TCT 2012

DESyneBD (Elixir Medical) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

TCT-100. Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results from the Global Valve-in-Valve Registry

Presenter: Danny Dvir

October 23, 2012

Presentation TCT 2012

TCT-2. Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000 Patients Enrolled in the SAPPHIRE Worldwide Study

Presenter: D. Christopher Metzger

October 23, 2012

Presentation TCT 2012

Yes: The Quantitative Threshold Should Be Lowered!

Presenter: Maurice Sarano

October 23, 2012

Presentation TCT 2012

TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial

Presenter: Eberhard Grube

October 23, 2012

Presentation TCT 2012

Counterpulsation with SYMPHONY for Chronic Heart Failure

Presenter: Robert Dowling

October 23, 2012

Advertisement

Slides

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

How to Become Trained and Start a LAA Closure Program

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

DESyneBD (Elixir Medical) Program Update

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

TCT-100. Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results from the Global Valve-in-Valve Registry

TCT-2. Peri-procedural Outcomes After Carotid Artery Stenting with the First 15,000 Patients Enrolled in the SAPPHIRE Worldwide Study

Yes: The Quantitative Threshold Should Be Lowered!

TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial

Counterpulsation with SYMPHONY for Chronic Heart Failure

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content